Peptide Storage Guide
Peptides are tough as a dry powder and fragile once they are in water. Almost every storage question comes back to that one difference. This guide covers how to store powder and mixed vials, what the fridge and freezer actually do, how long a vial lasts out of the fridge, what happens if you leave one out overnight, and the small habits that make the biggest difference.
The one rule that matters most
Dry is stable. Wet is not.
An FDA laboratory put this to the test on growth hormone. The same product was exposed to light as a freeze-dried powder, as a reconstituted solution, and as a diluted solution. The amount of clumped protein rose by 0.4% in the powder, 2.7% once reconstituted, and 4.7% once diluted. The chemical changes followed the same pattern, and the more dilute the sample, the worse it got.
That is the shape of the whole subject. While it is a sealed powder, a peptide can sit for a long time. The moment you add water, a clock starts, and the more water you add, the faster it ticks.
Storing the dry powder
Keep sealed vials cold, dark and dry. The fridge is fine for the shorter term and the freezer is the usual choice for long-term storage. Nobody has published a stability study on the research peptides sold online, so the month and year figures you see quoted are not from measured data. What is well established is the direction: a sealed, freeze-dried powder is far more durable than anything in solution.
Three practical points:
- Moisture is the real enemy. When freeze-dried protein takes up moisture, it clumps and loses activity, and the effect gets worse as humidity rises. That was shown clearly for lyophilised insulin. Keep the stopper sealed and the vial dry.
- Let a cold vial warm up before you open it. Opening a fridge-cold vial in a warm room pulls condensation onto the cold surfaces, which is exactly the moisture you were trying to avoid.
- Leave it in the box. Light matters. The licensed peptide Egrifta (tesamorelin) is stored in its original box to protect it from light, and that is a peptide sold for use at room temperature.
After you mix it: what sets the clock
Once a vial is reconstituted, two things decide how long it keeps: the temperature and what you mixed it with.
The diluent matters more than most people expect. One licensed product makes the comparison directly on its own label. Reconstituted with bacteriostatic water, it is good for 28 days at 2–8°C. Reconstituted with a preservative-free diluent, the same product in the same fridge gets 24 hours. The difference is the preservative, which is what makes a vial safe to enter more than once.
That is why 28 days keeps showing up. It is the in-use life of a preserved multi-dose vial, and you see the same number on teriparatide, which is discarded 28 days after first use.
There is no single correct number, though. Look at what approved peptide products actually allow after first use:
- Tesamorelin (reconstituted): room temperature, discard 7 days after mixing.
- Somatropin (growth hormone): 4 weeks in the fridge, or 3 weeks at room temperature no warmer than 25°C.
- Teriparatide: refrigerated at all times except while injecting, 28 days.
- Semaglutide pen: 56 days at 15–30°C or in the fridge once in use.
Seven days to fifty-six days, all of them peptides. The number comes from the formulation, not from the word "peptide".
The freezer
Freezing is good for powder and bad for solution.
Every licensed peptide injection says the same thing: do not freeze. Freezing damages peptides in water, and the damage is not mainly about the cold. When a solution freezes, ice surfaces form inside it and peptides clump at those surfaces. A growth hormone study found substantial aggregation on freezing driven by that interfacial stress. Repeated freeze-thaw cycles make it worse, which is why stability testing uses them as a standard stress.
So: freeze the powder if you are storing it for a long time, and never freeze a mixed vial. If a mixed vial freezes by accident, treat it as finished. The manufacturers say so plainly. The Wegovy label says to throw the pen or syringe away if it has been frozen.
What if you left it out overnight?
This is the most common worry and the answer is more reassuring than the internet suggests.
The best evidence comes from insulin, which has been studied properly. A 2023 Cochrane review pulled together 17 studies of insulin stored outside the recommended range. Several studies found no clinically relevant loss of activity in unopened vials and cartridges at temperatures between 28.9°C and 37°C for up to four months. Opened vials and cartridges held up at temperatures up to 37°C for as long as 12 weeks. Fluctuating temperatures between 25°C and 37°C over 12 weeks caused no measured loss either, and the studies that checked sterility found no microbial contamination. Two studies did find up to 18% loss of activity after one week to 28 days at 37°C, so heat does eventually matter.
The approved GLP-1 products build the same tolerance into their labels. Tirzepatide can be kept at up to 30°C for 21 days. Liraglutide gets 30 days at 15–30°C after first use. Semaglutide gets 56.
Against that, one night on a bench at normal room temperature is a small event. Two things are worth keeping in mind. First, those products are formulated, preserved and tested; a vial you mixed at home has none of that behind it, so the insulin data is a guide rather than a guarantee. Second, time out of the fridge adds up. The labels count it cumulatively — tirzepatide's 21 days is a total, not a fresh allowance each time. Put the vial back, note how long it was out, and keep a running total.
Don't over-dilute
Peptides stick to glass and plastic, and at low concentrations enough can be lost to matter. When the peptide cetrorelix was measured in water at 0.2 to 4 micrograms per millilitre, the readings came out low and inconsistent because the peptide was sticking to the walls of the vial. Glass was worse than polypropylene or polyethylene, and a more acidic solution reduced the loss.
Two takeaways. Mixing a vial very dilute is not a free way to make dosing easier, and this is part of why dilute acetic acid is used for some peptides rather than plain water.
Pre-filled syringes
The common advice is that a drawn-up syringe should be used within 24 hours. The published data on insulin is more generous. U-500 insulin in prefilled syringes held at least 93.3% of its starting concentration over 28 days refrigerated, and stayed above 97% for the first 21 days. The Cochrane review reached the same conclusion for prefilled syringes stored between 4°C and 23°C for up to 28 days.
That is insulin, not a research peptide, and a syringe is a less protective container than a sealed vial. But there is no evidence behind a strict 24-hour limit either. If you do prefill, keep them refrigerated, capped and upright, and let them come up to room temperature before injecting.
How to tell if something is wrong
Standard practice on every injectable label is to look at the solution before use and reject it if you see particles or a change in colour. Clear should be clear. A mixed peptide that has gone cloudy, developed strands or wisps, or changed colour should not be used.
For powder, look at the cake. It should be intact and dry. A cake that has slumped, gone glassy or looks sticky suggests moisture has got in.
The limit of this check is worth stating: a peptide can lose potency with nothing visible changing. Visual inspection catches obvious problems, not gradual decline. That is what the dating rules are for.
A routine that covers most of it
- Write the date on the vial when you mix it. This is the single most useful habit.
- Store in the body of the fridge, not the door. The door is the warmest part and swings the most every time it opens.
- Keep vials in their box or a closed storage case, away from light.
- Swirl, don't shake. Shaking and vortexing drive the same aggregation that freezing does.
- Wipe the septum with alcohol before each entry, use a fresh sterile needle and syringe every time, and never leave a needle parked in the stopper. CDC's guidance is that any vial should be discarded if sterility is compromised or questionable.
- One person per vial. Multi-dose vials are not shared.
- Travel cold. Use an insulated bag with a cold pack, keep the pack from touching the vial directly so it cannot freeze, and add the time to your running total.
Quick reference
- Sealed powder: fridge for the shorter term, freezer for longer. Dark and dry. Warm to room temperature before opening.
- Mixed with bacteriostatic water: fridge, and 28 days is the standard in-use life for a preserved multi-dose vial.
- Mixed with sterile water or plain saline: no preservative, so it is a single-use preparation. The licensed equivalent for a preservative-free diluent is 24 hours refrigerated.
- Mixed vials: never freeze.
- Pens and cartridges: follow the printed label. In-use allowances on approved products run from 21 to 56 days.
- Nasal sprays: preservative and container matter as much as temperature — covered in the Selank and Semax guide.
The short version
Keep it dry, cold and dark, and it will last. Mix it, and you have started a clock that runs faster with heat, light, dilution and time. Date the vial, keep it out of the fridge door, never freeze it once it is in solution, and don't panic about a single night on the bench — the peptide that has been studied most thoroughly for this shrugs off far worse.
References
- Pritts JD, Ortega-Rodriguez U, Rao VA. Physicochemical differences observed in photostability studies of lyophilized, reconstituted, and diluted somatropin. Pharm Res. 2026;43(1):185–193. View study
- Flores-Fernández GM, Solá RJ, Griebenow K. The relation between moisture-induced aggregation and structural changes in lyophilized insulin. J Pharm Pharmacol. 2009;61(11):1555–1561. View study
- Richter B, Bongaerts B, Metzendorf MI. Thermal stability and storage of human insulin. Cochrane Database Syst Rev. 2023;11(11):CD015385. View review
- Miyahara Y, Nagel R, Frieß W. Dissolved oxygen effects on human growth hormone stability during freeze-thaw and metal-catalyzed oxidation. J Pharm Sci. 2026;115(8):104316. View study
- Zäh M, Brandenbusch C, Artusio F, Sadowski G, Pisano R. DSC reveals the excipient impact on aggregation propensity of pharmaceutical peptides during freezing. Eur J Pharm Sci. 2025;204:106954. View study
- Grohganz H, Rischer M, Brandl M. Adsorption of the decapeptide Cetrorelix depends both on the composition of dissolution medium and the type of solid surface. Eur J Pharm Sci. 2004;21(2–3):191–196. View study
- Lull ME, Piacentino JJ, Traina AN. Stability of U-500 regular insulin in prefilled syringes. J Am Pharm Assoc. 2013;53(3):304–306. View study
- OZEMPIC (semaglutide) injection, prescribing information. Novo Nordisk. View label
- WEGOVY (semaglutide) injection, prescribing information. Novo Nordisk. View label
- MOUNJARO (tirzepatide) injection, prescribing information. Eli Lilly. View label
- SAXENDA (liraglutide) injection, prescribing information. Novo Nordisk. View label
- NORDITROPIN (somatropin) injection, prescribing information. Novo Nordisk. View label
- FORTEO (teriparatide) injection, prescribing information. Eli Lilly. View label
- EGRIFTA WR (tesamorelin) for injection, prescribing information. Theratechnologies. View label
- OGIVRI (trastuzumab-dkst) for injection, prescribing information — reconstitution with bacteriostatic versus preservative-free diluent. View label
- Centers for Disease Control and Prevention. Injection safety: clinical guidance. View guidance